ArticleNature communications2022

Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells.

M Kyle Cromer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.